Company Profile
Updated: 29-SEP-09Lorus Therapeutics Inc.
International public company
2 Meridian Rd., Toronto, ON M9W 4Z7, Canada
(416)7981200, (416)7982200 fax, http://www.lorusthera.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Pharmaceutical company focused on the development of cancer therapies.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
U.S. Patent Disclosures.
BIOWORLD Today; 11/4/2009; 949 words; ...kinase pathways. Chiral Quest Inc., of State College, Pa., said...of gene optimization methods. Lorus Therapeutics Inc., of Toronto, was awarded a...of immune system disorders." Lorus said the patent protects its intellectual...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2056 words; ...Gaithersburg, Md., said Aviagen Inc., of Huntsville, Ala., adopted...North American sites. o Insmed Inc., of Richmond, Va., reported...approval in that indication. o Lorus Therapeutics Inc., of Toronto, reported preclinical...
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1435 words; o ConjuChem Biotechnologies Inc., of Montreal, said it will be...2007.) o Javelin Pharmaceuticals Inc., of Cambridge, Mass., said...Data analyses are ongoing. o Lorus Therapeutics Inc., of Toronto, said enrollment...
Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 1143 words; ...commercial development. KBI BioPharma Inc., of Durham, N.C., appointed...fermentation operations. Kosan Biosciences Inc., of Hayward, Calif., promoted...executive director, medical affairs. Lorus Therapeutics Inc., of Toronto, appointed Paul...
Lorus Therapeutics Reports First Quarter Results for Fiscal Year 2010.(Financial report)
Marketwire Canada; 10/6/2009; 2455 words; ...Oct 6, 2009 (Marketwire via COMTEX) -- Lorus Therapeutics Inc. (the "Company" or "Lorus") (TSX:LOR), a biopharmaceutical company...said Dr. Aiping Young, President and CEO of Lorus. FINANCIAL RESULTS The loss from operations...
Recent News Articles
- Lorus Therapeutics Inc - Financial and Strategic Analysis Review.
M2 Presswire - May 04, 2009 - Lorus Therapeutics Inc-Financial Company Report.
M2 Presswire - February 17, 2009 - Lorus Therapeutics Inc.-Deals & Alliances Report.
M2 Presswire - February 10, 2009 - Lorus receives $150,000 milestone from Zor.(Lorus Therapeutics Inc.)(Zor Pharmaceuticals)(Brief article)
Pharma Marketletter - October 27, 2008
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning